RAPP SG&A Expense Growth

Rapport Therapeutics Inc · SG&A Expense Growth

RAPP logo

RAPP SG&A Expense Growth

Latest reported37.03%
RAPP FY SG&A Growth (YoY) (0.00% → 37.03%)
High-resolution chart · PNG

RAPP sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Rapport Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
37.0253%
170.4156%
498.9085%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.